Interestingly, the metabolo-oncogenic nature of FASN in breast cancer does not rely on its lactogenic activity, but rather on its ability to provide energy, macromolecules for membrane synthesis, and lipid signals, that facilitate cancer cell survival and proliferation, and also regulate the activity of other oncogenic pathways [33–37]. The gene discussed is FASN; the disease is breast carcinoma.